Corteva, Inc. (NYSE:CTVA) Shares Sold by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. lessened its holdings in Corteva, Inc. (NYSE:CTVA) by 20.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,706 shares of the company’s stock after selling 2,770 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Corteva were worth $617,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva during the 1st quarter worth approximately $25,000. Rise Advisors LLC increased its position in Corteva by 2,522.2% in the first quarter. Rise Advisors LLC now owns 472 shares of the company’s stock worth $27,000 after buying an additional 454 shares during the period. Albion Financial Group UT increased its position in Corteva by 77.2% in the first quarter. Albion Financial Group UT now owns 505 shares of the company’s stock worth $29,000 after buying an additional 220 shares during the period. CVA Family Office LLC acquired a new position in shares of Corteva during the fourth quarter valued at $25,000. Finally, Ironwood Wealth Management Inc. boosted its holdings in shares of Corteva by 106.1% during the first quarter. Ironwood Wealth Management Inc. now owns 544 shares of the company’s stock valued at $31,000 after acquiring an additional 280 shares during the period. Institutional investors own 81.54% of the company’s stock.

Insider Transactions at Corteva

In related news, insider Samuel R. Eathington sold 31,686 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $57.64, for a total value of $1,826,381.04. Following the transaction, the insider now directly owns 53,854 shares of the company’s stock, valued at approximately $3,104,144.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider Samuel R. Eathington sold 31,686 shares of the firm’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $57.64, for a total value of $1,826,381.04. Following the transaction, the insider now directly owns 53,854 shares in the company, valued at approximately $3,104,144.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian Titus sold 12,134 shares of Corteva stock in a transaction on Monday, May 6th. The stock was sold at an average price of $56.65, for a total transaction of $687,391.10. Following the completion of the transaction, the insider now owns 13,495 shares in the company, valued at approximately $764,491.75. The disclosure for this sale can be found here. In the last quarter, insiders sold 83,556 shares of company stock worth $4,795,016. 0.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Barclays lifted their price objective on shares of Corteva from $55.00 to $58.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 10th. Mizuho reduced their price objective on Corteva from $61.00 to $60.00 and set a “buy” rating for the company in a research report on Tuesday, June 18th. Canaccord Genuity Group raised their target price on Corteva from $60.00 to $65.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. KeyCorp upped their price target on shares of Corteva from $63.00 to $66.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 9th. Finally, OTR Global reiterated a “negative” rating on shares of Corteva in a research note on Friday, June 7th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $63.00.

Corteva Stock Down 0.8 %

CTVA stock traded down $0.42 during mid-day trading on Friday, hitting $54.78. The stock had a trading volume of 2,088,346 shares, compared to its average volume of 3,026,307. The company has a fifty day moving average of $53.89 and a 200 day moving average of $53.37. Corteva, Inc. has a 1-year low of $43.22 and a 1-year high of $58.76. The stock has a market capitalization of $38.18 billion, a price-to-earnings ratio of 69.34, a PEG ratio of 1.48 and a beta of 0.77. The company has a current ratio of 1.51, a quick ratio of 0.97 and a debt-to-equity ratio of 0.10.

Corteva (NYSE:CTVA) last posted its earnings results on Wednesday, May 1st. The company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.79 by $0.10. The company had revenue of $4.49 billion during the quarter, compared to the consensus estimate of $4.65 billion. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The company’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.16 earnings per share. On average, equities analysts expect that Corteva, Inc. will post 2.79 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th were issued a dividend of $0.16 per share. The ex-dividend date was Tuesday, June 4th. This represents a $0.64 annualized dividend and a yield of 1.17%. Corteva’s dividend payout ratio (DPR) is currently 81.01%.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.